These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10228137)
1. Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strain. Bonay M; Bouchonnet F; Pelicic V; Lagier B; Grandsaigne M; Lecossier D; Grodet A; Vokurka M; Gicquel B; Hance AJ Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1629-37. PubMed ID: 10228137 [TBL] [Abstract][Full Text] [Related]
2. Effects of diesel particles on the control of intracellular mycobacterial growth by human macrophages in vitro. Bonay M; Chambellan A; Grandsaigne M; Aubier M; Soler P FEMS Immunol Med Microbiol; 2006 Apr; 46(3):419-25. PubMed ID: 16553816 [TBL] [Abstract][Full Text] [Related]
3. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. Wang J; Wakeham J; Harkness R; Xing Z J Clin Invest; 1999 Apr; 103(7):1023-9. PubMed ID: 10194475 [TBL] [Abstract][Full Text] [Related]
4. Culture at high density improves the ability of human macrophages to control mycobacterial growth. Boechat N; Bouchonnet F; Bonay M; Grodet A; Pelicic V; Gicquel B; Hance AJ J Immunol; 2001 May; 166(10):6203-11. PubMed ID: 11342642 [TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production. Gagliardi MC; Teloni R; Giannoni F; Pardini M; Sargentini V; Brunori L; Fattorini L; Nisini R J Leukoc Biol; 2005 Jul; 78(1):106-13. PubMed ID: 15845642 [TBL] [Abstract][Full Text] [Related]
6. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. Wakeham J; Wang J; Magram J; Croitoru K; Harkness R; Dunn P; Zganiacz A; Xing Z J Immunol; 1998 Jun; 160(12):6101-11. PubMed ID: 9637527 [TBL] [Abstract][Full Text] [Related]
7. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Sander B; Skansén-Saphir U; Damm O; Håkansson L; Andersson J; Andersson U Immunology; 1995 Dec; 86(4):512-8. PubMed ID: 8567014 [TBL] [Abstract][Full Text] [Related]
9. Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages. Denis M; Wedlock DN; Buddle BM Cell Immunol; 2004; 232(1-2):1-8. PubMed ID: 15922710 [TBL] [Abstract][Full Text] [Related]
10. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG). Marras F; Bozzano F; Bentivoglio G; Ugolotti E; Biassoni R; Moretta L; De Maria A Eur J Immunol; 2012 Sep; 42(9):2459-70. PubMed ID: 22736333 [TBL] [Abstract][Full Text] [Related]
11. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. Murray PJ; Wang L; Onufryk C; Tepper RI; Young RA J Immunol; 1997 Jan; 158(1):315-21. PubMed ID: 8977205 [TBL] [Abstract][Full Text] [Related]
12. GM-CSF-mediated T-cell activation by macrophages infected with recombinant BCG that secretes major membrane protein-II of Mycobacterium leprae. Makino M; Maeda Y; Kai M; Tamura T; Mukai T FEMS Immunol Med Microbiol; 2009 Jan; 55(1):39-46. PubMed ID: 19076223 [TBL] [Abstract][Full Text] [Related]
13. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages]. Sato K; Tomioka H; Saito H Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673 [TBL] [Abstract][Full Text] [Related]
14. CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette-Guérin. Mukai T; Maeda Y; Tamura T; Miyamoto Y; Makino M FEMS Immunol Med Microbiol; 2008 Jun; 53(1):96-106. PubMed ID: 18400013 [TBL] [Abstract][Full Text] [Related]
15. Cytokine interactions that determine the outcome of Mycobacterial infection of macrophages. Reljic R; Stylianou E; Balu S; Ma JK Cytokine; 2010 Jul; 51(1):42-6. PubMed ID: 20434357 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Esin S; Batoni G; Pardini M; Favilli F; Bottai D; Maisetta G; Florio W; Vanacore R; Wigzell H; Campa M Immunology; 2004 May; 112(1):143-52. PubMed ID: 15096193 [TBL] [Abstract][Full Text] [Related]
17. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages. Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901 [TBL] [Abstract][Full Text] [Related]
19. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. Flesch I; Kaufmann SH J Immunol; 1987 Jun; 138(12):4408-13. PubMed ID: 3108389 [TBL] [Abstract][Full Text] [Related]
20. Assessment of in vitro immunity to Mycobacterium tuberculosis in a human peripheral blood infection model using a luciferase reporter construct of M. tuberculosis H37Rv. Al-Attiyah R; El-Shazly A; Mustafa AS Clin Exp Immunol; 2006 Sep; 145(3):520-7. PubMed ID: 16907922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]